LOADING
Comparing AbbVie Inc (ABBV) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | NKE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $454.4B | $54.6B |
| P/E Ratio | 72.4 | 17.5 |
| Forward P/E | 15.9 | 21.4 |
| PEG Ratio | 0.53 | 1.43 |
| EPS | $3.55 | $2.10 |
| Revenue Growth (YoY) | 10.2% | -1.1% |
| Profit Margin | 9.8% | 6.7% |
| Return on Equity | 62.3% | 22.1% |
| Dividend Yield | 2.68% | 4.45% |
| Beta | 0.28 | 1.11 |
| 52-Week High | $267.47 | $74.51 |
| 52-Week Low | $189.40 | $36.55 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Nike Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Nike Inc offers a higher dividend yield for income investors. AbbVie Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.